ApoB (apolipoprotein B) is a structural protein of LDL and VLDL particles, primarily responsible for lipid transport in the blood. It does not play a direct role in blood sugar regulation. However, observational studies consistently show that elevated ApoB levels are associated with insulin resistance and type 2 diabetes. The link is indirect: ApoB-containing lipoproteins can promote oxidative stress and inflammation, impairing insulin signaling. Additionally, ApoB is a marker of atherogenic dyslipidemia, often present in metabolic syndrome. The evidence is based on epidemiological and mechanistic studies, not on randomized controlled trials proving causality. Therefore, ApoB is not a direct regulator of blood glucose but a valuable risk marker for cardiometabolic disease. Elevated levels warrant comprehensive metabolic assessment, including fasting glucose, HbA1c, and lipid panel.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-687f13c376af22e40d0f3242